Thematische Bibliographien / Early Detection of Parkinson's Disease / Bücher
Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Early Detection of Parkinson's Disease.

Bücher zum Thema „Early Detection of Parkinson's Disease“

Autor: Grafiati
Veröffentlicht am 12. April 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Bücher für die Forschung zum Thema "Early Detection of Parkinson's Disease" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Bücher für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

E, Lyons Kelly, Hrsg. Management of early Parkinson's disease. [Oxford]: Oxford University Press, 2009.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

P, Dostert, Erbamont Inc und Fondazione Carlo Erba, Hrsg. Early markers in Parkinson's and Alzheimer's diseases. Wien: Springer-Verlag, 1990.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Carlos, Kaski Juan, und Holt David W, Hrsg. Myocardial damage: Early detection by novel biochemical markers. Dordrecht: Kluwer Academic, 1998.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

1933-, Fahn Stanley, Hrsg. Parlodel® (bromocriptine mesylate) in the early management of Parkinson's disease: Excerpts from Recent developments in Parkinson's disease, volume 2. Florham Park, N.J: Macmillan Healthcare Information, 1987.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

McCarthy, Joseph C. Early hip disorders: Advances in detection and minimally invasive treatment. New York: Springer, 2011.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

name, No. Early hip disorders: Advances in detection and minimally invasive treatment. New York, NY: Springer, 2003.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

editor, Mordini E. (Emilio), und Green Manfred editor, Hrsg. Internet-based intelligence in public health emergencies: Early detection and response in disease outbreak crises. Amsterdam, Netherlands: IOS Press, 2011.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Long, Katrina M. Pre-active PD: A Therapist Delivered Physical Activity Behavior Change Program for People With Early Stage Parkinson's Disease. [New York, N.Y.?]: [publisher not identified], 2020.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Fitzgerald, Rebecca C. Pre-invasive disease: Pathogenesis and clinical management. New York: Springer, 2011.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Christophe, Trivalle, Hrsg. Gérontologie préventive: Éléments de prévention du vieillissement pathologique. Paris: Masson, 2002.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
11

Patlak, Margie. Mammography and beyond: Developing technologies for the early detection of breast cancer : a non-technical summary. Herausgegeben von National Cancer Policy Board (U.S.). Committee on the Early Detection of Breast Cancer und National Research Council (U.S.). Commission on Life Sciences. Washington, D.C: National Academy Press, 2001.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
12

Wells, F. O. Preventive medicine: Working for patients : a review of the therapeutic areas where screening programmes and the early detection and treatment of disease will benefit patients and the NHS. London: Association of the British Pharmaceutical Industry, 1989.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
13

Lyons, Kelly E., und Rajesh Pahwa. Early Recognition and Diagnosis in Parkinson's Disease. Oxford University Press, 2010.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
14

Hoyle, Nicholas R., Thompson Michael, Richard Morgan, Subrayal M. Reddy und Damien Arrigan. Early Detection of Biomarkers for Disease. Royal Society of Chemistry, The, 2017.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
15

Early diagnosis and preventive therapy in Parkinson's disease. Wien: Springer-Verlag, 1989.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
16

Riederer, Peter, und Horst Przuntek. Early Diagnosis and Preventive Therapy in Parkinson's Disease. Springer London, Limited, 2012.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
17

Riederer, Peter, und Horst Przuntek. Early Diagnosis and Preventive Therapy in Parkinson's Disease. Lar, 1989.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
18

Early Diagnosis and Preventive Therapy in Parkinson's Disease. Springer, 2012.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
19

Blake-Krebs, M. A. Barbara, M.L.S., Linda Herman und R.N., L.C.S.W., Susan Reese. When Parkinson's Strikes Early: Voices, Choices, Resources, and Treatment. Hunter House Publishers, 2001.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
20

Early Detection of Alzheimer's Disease: A Neuropsychological Approach. Academic & Scientific Publishers, 2008.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
21

Gao, Youhe. Urine: Promising Biomarker Source for Early Disease Detection. Springer, 2019.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
22

Albert, Marilyn S., und Guy M. Mckhann. Neuroethical Issues In Early Detection Of Alzheimer’S Disease. Oxford University Press, 2011. http://dx.doi.org/10.1093/oxfordhb/9780199570706.013.0135.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
23

Gao, Youhe. Urine: Promising Biomarker Source for Early Disease Detection. Springer Singapore Pte. Limited, 2020.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
24

(Editor), J. C. Kaski, und David W. Holt (Editor), Hrsg. Myocardial Damage: Early Detection by Novel Biochemical Markers. Springer, 1998.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
25

Holt, David W., und Juan Carlos Kaski. Myocardial Damage: Early Detection by Novel Biochemical Markers. Springer London, Limited, 2013.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
26

Myocardial Damage: Early Detection by Novel Biochemical Markers. Springer Netherlands, 2010.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
27

Chan, Dennis. Early Detection in Alzheimer's Disease: Biological and Technological Advances. Academic Press, 2021.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
28

Chan, Dennis. Early Detection in Alzheimer's Disease: Biological and Technological Advances. Elsevier Science & Technology Books, 2021.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
29

Edoh, Thierry. Pre-Screening Systems for Early Disease Prediction, Detection, and Prevention. IGI Global, 2018.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
30

C, Morris John, und Jeffrey M. Burns. Mild Cognitive Impairment and Early Alzheimer's Disease: Detection and Diagnosis. Wiley & Sons, Incorporated, John, 2008.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
31

Diffusion Tensor Imaging and Fractional Anisotropy: Imaging Biomarkers in Early Parkinson's Disease. Springer, 2023.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
32

Kotian, Rahul P., und Prakashini Koteshwar. Diffusion Tensor Imaging and Fractional Anisotropy: Imaging Biomarkers in Early Parkinson's Disease. Springer, 2022.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
33

Treasures in the Darkness: Extending the Early Stage of Lewy Body Dementia, Alzheimer's, and Parkinson's Disease. CreateSpace Independent Publishing Platform, 2012.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
34

Roze, Emmanuel, und Nenad Blau. Biogenic Monoamine Disorders. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199972135.003.0031.

Der volle Inhalt der Quelle
Annotation:
Biogenic monoamine disorders are a group of inherited diseases characterized by a defect in the synthesis, transport, or degradation of catecholamines and serotonin. The phenotype mostly reflects the pattern and severity of the monoamine deficiency. Movement disorders due to cerebral dopamine deficiency are almost always prominent, mostly in the form of dystonia and/or parkinsonism. These disorders are potentially devastating yet treatable. Early diagnosis and treatment are crucial to prevent ongoing brain dysfunction. Detection of hyperphenylalaninemia in a neonate could be a good clue to the diagnosis. Final diagnosis is often based on a detailed biochemical investigation of the cerebrospinal fluid and can be confirmed by molecular analysis. Treatment is aimed at restoring neurotransmitter homeostasis using monoamine precursors, monoamine agonists, and inhibitors of monoamine degradation. It also comprises the control of hyperphenylalaninemia and the prevention of cerebral folate deficiency, when applicable.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
35

Lemiere, Jurgen. Huntington's Disease: Early Detection & Progression of Cognitive Changes in Patients & Asymptomatic Mutation Carriers (Acta Biomedica Lovaniensia). Leuven Univ Pr, 2004.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
36

Fitzgerald, Rebecca C. Pre-Invasive Disease: Pathogenesis and Clinical Management. Springer, 2014.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
37

Martinez, Jaun Jair. An international telemedicine model design: Using e-health to improve chronic disease early detection and initial management in rural areas. 2005.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
38

Kelly, Laura, und William P. Stanford. Implementation of Personalized Precision Medicine: Expanding the Clinical Vision Towards Prevention, Early Detection and Precision Treatment of Disease to Drive Extended Healthspan. Elsevier Science & Technology, 2023.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
39

Kelly, Laura, und William P. Stanford. Implementation of Personalized Precision Medicine: Expanding the Clinical Vision Towards Prevention, Early Detection and Precision Treatment of Disease to Drive Extended Healthspan. Elsevier Science & Technology Books, 2023.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
40

Chneiweiss, Hervé. Anticipating a therapeutically elusive neurodegenerative condition: Ethical considerations for the preclinical detection of Alzheimer’s disease. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780198786832.003.0016.

Der volle Inhalt der Quelle
Annotation:
Among neurodegenerative disorders, Alzheimer’s disease has held a special position during the last 40 years. It represents a huge burden of disease with more than 40 million people affected worldwide. The economic effect it has on society is enormous, and the specific challenges of dementia are tremendous. Now that science has demonstrated that the disease starts two or three decades before any symptoms occur, possibilities exist for diagnosis or testing increasingly early through the capabilities of predictive medicine. The related ethical debate is on the multiple meanings and the impact of preclinical diagnosis of Alzheimer’s disease before the onset of symptoms. To guide this discussion, this chapter draws upon lessons from other fields of medicine and the identification of high-risk individuals bearing pathogenic genetic mutations that predispose them to the disease. It concludes with thoughts on value and choice in the complex, fine balance between anticipating, knowing, and doing.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
41

Keshav, Satish, und Alexandra Kent. Screening for gastrointestinal disease. Herausgegeben von Patrick Davey und David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0354.

Der volle Inhalt der Quelle
Annotation:
This chapter discusses screening for gastrointestinal disease, including Barrett’s oesophagus (BO), colorectal cancer, and hepatocellular cancer (HCC). In patients with BO, approximately 5% will develop dysplasia, and 10%–50% of the low-grade dysplasias will progress to high-grade dysplasia or adenocarcinoma within 2–5 years. Thus, screening for BO has been developed to reduce the development of adenocarcinoma via the early detection of high-grade dysplasia or cancer in situ. The main aim of colorectal cancer screening is the early detection of polyps and cancers, at a time when treatment is likely to be more effective. Similarly, early detection of HCC is advantageous, as the prognosis in advanced disease is very poor. This chapter describes the current processes of screening for these diseases, and the impact of this screening, as well as screening for gastrointestinal cancer in specific groups.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
42

Trivalle, Christophe. Gérontologie préventive : Eléments de prévention du vieillissement pathologique. Editions Masson, 2002.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
43

Grassberger, Martin, Ronald A. Sherman und Olga S. Gileva. Biotherapy - History, Principles and Practice: A Practical Guide to the Diagnosis and Treatment of Disease using Living Organisms. Springer, 2013.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
44

Kim, Christopher, Martin Grassberger, Ronald A. Sherman, Olga S. Gileva und Kosta Mumcuoglu. Biotherapy - History, Principles and Practice: A Practical Guide to the Diagnosis and Treatment of Disease Using Living Organisms. Springer London, Limited, 2013.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
45

Kim, Christopher, Martin Grassberger, Ronald A. Sherman, Olga S. Gileva und Kosta Mumcuoglu. Biotherapy - History, Principles and Practice: A Practical Guide to the Diagnosis and Treatment of Disease using Living Organisms. Springer, 2013.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
46

Kim, Christopher, Martin Grassberger, Ronald A. Sherman, Olga S. Gileva und Kosta Mumcuoglu. Biotherapy - History, Principles and Practice: A Practical Guide to the Diagnosis and Treatment of Disease using Living Organisms. Springer, 2015.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
47

Tribouilloy, Christophe, Patrizio Lancellotti, Ferande Peters, José Juan Gómez de Diego und Luc A. Pierard. Heart valve disease (aortic valve disease): aortic regurgitation. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198726012.003.0033.

Der volle Inhalt der Quelle
Annotation:
Echocardiography is the cornerstone examination for the assessment of aortic regurgitation (AR): it provides reliable evaluation of the aortic valve and allows diagnosis and identification of the mechanism of regurgitation. The specific aetiology of the disease can be identified in the majority of cases. A combination of quantitative and quantitative Doppler and two-dimensional (2D) echocardiographic parameters allows the evaluation of the severity of AR and determination of the haemodynamic and left ventricular function repercussions. Echocardiography allows the detection of associated lesions of the aortic root or other valves. In symptomatic patients, echocardiography is essential to confirm the severity of AR. In asymptomatic patients with moderate or severe AR, echocardiography is essential for regular follow-up, by providing precise and reproducible measurements of LV dimensions and function, and for identifying patients who should be considered for elective surgical intervention. In most cases, transthoracic echocardiography (TTE) provides all of the necessary information and transoesophageal echocardiography in usually not required. Real-time three-dimensional (3D) TTE can be complementary to 2D echocardiography for the assessment of the mechanism and quantification of AR by increasing the level of confidence, especially when 2D echocardiographic data are inconclusive or discordant with clinical findings. Tissue Doppler imaging and especially the speckle tracking method are promising approaches to detect early LV dysfunction in patients with asymptomatic severe AR. Echocardiography is therefore the key examination for the assessment of AR and at the centre of the strategic discussion concerning the indications and timing of surgery.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
48

Zika Virus Disease. Exon Publications, 2024. http://dx.doi.org/10.36255/zika-virus-disease.

Der volle Inhalt der Quelle
Annotation:
Zika Virus Disease is a mosquito-borne illness that can cause mild symptoms such as fever, rash, and joint pain but is particularly concerning for its potential to cause severe birth defects and neurological complications. This article provides a detailed understanding of Zika Virus Disease, serving as a valuable resource for the public. The article begins with an introduction to the virus, explaining its origins and primary modes of transmission. It covers the causes of infection, including how the virus is transmitted by mosquitoes and other methods. The article discusses the different strains of the virus, risk factors, and how common the disease is. Readers will learn about the signs and symptoms, how the disease spreads, and the methods used for diagnosis. The pathophysiology of the virus is explained, along with the treatment options available, which mainly focus on supportive care. Preventive measures are outlined to help reduce the risk of infection. The article concludes with a summary emphasizing the importance of early detection, appropriate treatment, and preventive measures. All information is presented in simple terms to ensure it is understandable for all readers.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
49

Chakera, Aron, William G. Herrington und Christopher A. O’Callaghan. Prevention of kidney disease. Herausgegeben von Patrick Davey und David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0345.

Der volle Inhalt der Quelle
Annotation:
A number of factors are known to predispose to renal disease, such as diabetes mellitus, hypertension, and exposure to certain drugs or substances (e.g. mercury and other heavy metals). In people who are at risk for these reasons, renal function should be regularly monitored as part of routine care. Kidney diseases are identified by elevations in the serum creatinine; the presence in the urine of blood, protein, or elevated levels of certain electrolytes; or evidence of anatomical abnormalities. Due to the large functional reserve of the kidneys, symptoms of impaired renal function usually occur late in the course of disease, highlighting the importance of early detection and, where available, the use of ameliorating therapies.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
50

Morrison, Karen. Prevention of cerebrovascular disease. Herausgegeben von Patrick Davey und David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0348.

Der volle Inhalt der Quelle
Annotation:
Stroke is the main cause of neurological morbidity in adults and the third most common cause of death worldwide after ischaemic heart disease and cancer (all forms combined). It is more common in older people, with three-quarters of strokes occurring in people over 65 years of age, and estimates are that overall stroke morbidity will double by the early 2020s. The worldwide figure of increasing incidence of stroke detection masks the fact that mortality from stroke has actually been falling in developed countries since the latter half of the twentieth century while the mortality has continued to rise in China, Asia, and eastern Europe. This chapter discusses prevention of cerebrovascular disease, and includes strategies to reduce the risk of thromboembolic stroke and cerebral haemorrhage.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Die Auswahlen zum Thema "Early Detection of Parkinson's Disease" für andere Quellenarten können Sie auch interessieren:
Zeitschriftenartikel Dissertationen
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie